Avandia was approved in 1999. In 2007, a study found the diabetes drug posed an increased risk of heart attack. (Jb Reed/Bloomberg News)
FDA panel backs Avandia although concerns linger
Avandia was approved in 1999. In 2007, a study found the diabetes drug posed an increased risk of heart attack. (Jb Reed/Bloomberg News)
A Food and Drug Administration advisory panel recommended yesterday that the diabetes drug Avandia be allowed to remain on the market despite a variety of studies that show it poses elevated risks of heart attack. (Full article: 996 words)
This article is available in our archives:
Globe Subscribers
FREE for subscribers
Subscribers to the Boston Globe get unlimited access to our archives.
Not a subscriber?
Non-Subscribers
Purchase an electronic copy of the full article. Learn More
- $4.95 1 article
- $9.95 4 articles
- $25.95 Monthly
Waiting for Twitter to feed in the latest...